NEWS & VIEWS

Global private equity and venture capital news and research

Posts Tagged ‘OrbiMed’

18 July 2014

Roka Bioscience raised $60m via Nasdaq IPO

biotech Venture capital-backed molecular diagnostics specialist Roka Bioscience has raised $60m via an IPO on the Nasdaq exchange.

30 May 2014

KPCB, OrbiMed, DAG renew commitment to ARMO BioSciences in $30m Series B

medical cell disease virus health A trio of venture capital investors have reaffirmed their commitment to ARMO BioSciences by backing a $30m Series B financing round.

23 April 2014

OrbiMed leads $22m round for Aerpio Therapeutics

biotech_lrg Biopharmaceutical startup Aerpio Therapeutics has secured $22m in a round led by venture capital firm OrbiMed.

10 March 2014

Healthcare developer Domain Surgical scores $35m investment round

Domain Surgical, a developer of advanced thermal surgical technology, has closed a $35m equity and debt financing round led by healthcare-focused investment firm OrbiMed.

27 February 2014

CalSTRS commits nearly $950m to private equity funds

california2_sq The California State Teachers Retirement System backed Carlyle's latest flagship fund and several other private equity vehicles in the final quarter of 2013.

24 February 2014

OrbiMed backs breast implant maker GC Aesthetics

Eurosilicone2 Breast implant maker GC Aesthetics has secured a $40m investment from new investor OrbiMed on top of a $20m capital injection from its existing backers Montreux Equity Partners and Oyster Capital.

1 November 2013

OrbiMed eyes ‘exciting time’ for healthcare deals with $735m fund close

Healthcare-focused investment firm OrbiMed has held a $735m final close for its latest venture capital fund.

3 October 2013

OrbiMed joins Aisling in $33m Loxo Oncology Series A round

Founding Loxo Oncology investor Aisling Capital has upped its commitment to the cancer treatment biopharma business by taking part in a $33m Series A financing round.

21 August 2012

GE teams with life sciences investor OrbiMed in $20m Series B for Israel’s Ornim

blood_vein_170sq GE together with life sciences investor OrbiMed Israel has led a $20 m investment in medical device developer Ornim.


Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2014